A61K 39/39558(20130101), A61K 31/7064(20130101), A61K 33/24(20130101), A61K 39/39533(20130101), C07K 16/32(20130101), C07K 2317/73(20130101)
This application relates to combination therapies including triciribine and related compounds and trastuzumab or a salt thereof and compositions with reduced toxicity for the treatment and prevention of tumors, cancer, and other disorders associated with abnormal cell proliferation.
Cheng, Jin Q. and Sebti, Said M., "Compositions including triciribine and trastuzumab and methods of use thereof" (2015). USF Patents. 69.
University of South Florida